Comerica Securities’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $210K | Sell |
3,980
-20,205
| -84% | -$1.06M | 0.02% | 429 |
|
|
2023
Q2 | $1.31M | Buy |
24,185
+205
| +0.9% | +$10.7K | 0.09% | 200 |
|
|
2023
Q1 | $1.2M | Buy |
23,980
+1,669
| +7% | +$78.7K | 0.09% | 206 |
|
|
2022
Q4 | $1.03M | Sell |
22,311
-406
| -2% | -$17.6K | 0.07% | 228 |
|
|
2022
Q3 | $880K | Sell |
22,717
-213
| -0.9% | -$8.54K | 0.07% | 220 |
|
|
2022
Q2 | $855K | Buy |
22,930
+683
| +3% | +$27.8K | 0.06% | 241 |
|
|
2022
Q1 | $985K | Sell |
22,247
-3,333
| -13% | -$144K | 0.07% | 225 |
|
|
2021
Q4 | $1.09M | Buy |
25,580
+740
| +3% | +$31.1K | 0.07% | 222 |
|
|
2021
Q3 | $1.08M | Buy |
24,840
+539
| +2% | +$23.8K | 0.08% | 216 |
|
|
2021
Q2 | $1.04M | Buy |
24,301
+4,093
| +20% | +$172K | 0.08% | 219 |
|
|
2021
Q1 | $781K | Buy |
20,208
+3,051
| +18% | +$115K | 0.06% | 248 |
|
|
2020
Q4 | $617K | Sell |
17,157
-2,263
| -12% | -$81.6K | 0.05% | 265 |
|
|
2020
Q3 | $742K | Sell |
19,420
-1,722
| -8% | -$66.4K | 0.07% | 223 |
|
|
2020
Q2 | $742K | Buy |
21,142
+10,848
| +105% | +$391K | 0.07% | 219 |
|
|
2020
Q1 | $336K | Sell |
10,294
-12,423
| -55% | -$485K | 0.04% | 296 |
|
|
2019
Q4 | $1.03M | Sell |
22,717
-1,259
| -5% | -$52.7K | 0.1% | 195 |
|
|
2019
Q3 | $976K | Buy |
23,976
+2,031
| +9% | +$86K | 0.1% | 194 |
|
|
2019
Q2 | $943K | Buy |
21,945
+498
| +2% | +$19.2K | 0.1% | 193 |
|
|
2019
Q1 | $823K | Buy |
21,447
+4,729
| +28% | +$181K | 0.09% | 211 |
|
|
2018
Q4 | $591K | Sell |
16,718
-26
| -0.2% | -$943 | 0.08% | 226 |
|
|
2018
Q3 | $645K | Buy |
16,744
+2,157
| +15% | +$75.3K | 0.08% | 241 |
|
|
2018
Q2 | $477K | Buy |
14,587
+154
| +1% | +$4.64K | 0.06% | 280 |
|
|
2018
Q1 | $394K | Buy |
14,433
+714
| +5% | +$19.4K | 0.05% | 293 |
|
|
2017
Q4 | $340K | Buy |
13,719
+571
| +4% | +$15.7K | 0.04% | 314 |
|
|
2017
Q3 | $384K | Buy |
13,148
+1,670
| +15% | +$46.1K | 0.05% | 290 |
|
|
2017
Q2 | $318K | Buy |
11,478
+99
| +0.9% | +$2.63K | 0.05% | 308 |
|
|
2017
Q1 | $283K | Buy |
+11,379
| New | +$277K | 0.04% | 319 |
|
|
2016
Q4 | – | Sell |
-11,085
| Closed | -$264K | – | 349 |
|
|
2016
Q3 | $264K | Buy |
11,085
+103
| +0.9% | +$2.46K | 0.05% | 292 |
|
|
2016
Q2 | $257K | Buy |
10,982
+31
| +0.3% | +$671 | 0.05% | 296 |
|
|
2016
Q1 | $206K | Buy |
10,951
+136
| +1% | +$2.39K | 0.05% | 328 |
|
|
2015
Q4 | $199K | Buy |
10,815
+156
| +1% | +$2.79K | 0.05% | 311 |
|
|
2015
Q3 | $175K | Hold |
10,659
| – | – | 0.05% | 310 |
|
|
2015
Q2 | $189K | Buy |
+10,659
| New | +$190K | 0.05% | 325 |
|
Other funds holding BSX
Comerica Securities's BSX Position: Q3 2023 in Review
Comerica Securities reduced its Boston Scientific (BSX) stake by 84% in Q3 2023, selling an estimated $1.06M and leaving 3,980 shares worth $210K. The position accounts for 0.02% of the portfolio, ranked #429.
Comerica Securities first reported a position in BSX in Q2 2015 and has held it in 33 quarters since. The position peaked at $1.31M in Q2 2023. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.
- Comerica Securities held 3,980 shares of Boston Scientific worth $210K as of Q3 2023.
- Comerica Securities sold 20,205 Boston Scientific shares in Q3 2023, an estimated $1.06M.
- Boston Scientific made up 0.02% of Comerica Securities's portfolio in Q3 2023, its #429 holding.
- Comerica Securities first reported a position in Boston Scientific in Q2 2015 and has held it in 33 quarters since.
- Comerica Securities's Boston Scientific position peaked at $1.31M in Q2 2023.
- 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.
Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.